Form 8-K - Current report:
SEC Accession No. 0002032966-25-000017
Filing Date
2025-05-15
Accepted
2025-05-15 07:18:07
Documents
15
Period of Report
2025-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cik0002032966-20250513.htm   iXBRL 8-K 29362
2 EX-99.1 acurencorporation-x1q25ear.htm EX-99.1 239861
3 EX-99.2 acurencorporation-nyseupli.htm EX-99.2 7726
  Complete submission text file 0002032966-25-000017.txt   421605

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cik0002032966-20250513.xsd EX-101.SCH 1830
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cik0002032966-20250513_lab.xml EX-101.LAB 21230
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cik0002032966-20250513_pre.xml EX-101.PRE 12068
17 EXTRACTED XBRL INSTANCE DOCUMENT cik0002032966-20250513_htm.xml XML 2747
Mailing Address 14434 MEDICAL COMPLEX DRIVE #100 TOMBALL TX 77377
Business Address 14434 MEDICAL COMPLEX DRIVE #100 TOMBALL TX 77377 800-218-7450
ACUREN CORP (Filer) CIK: 0002032966 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42524 | Film No.: 25948686
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)